David R. Lowry

865 total citations
17 papers, 671 citations indexed

About

David R. Lowry is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, David R. Lowry has authored 17 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Internal Medicine. Recurrent topics in David R. Lowry's work include Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Acute Myocardial Infarction Research (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). David R. Lowry is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Acute Myocardial Infarction Research (5 papers) and Atrial Fibrillation Management and Outcomes (4 papers). David R. Lowry collaborates with scholars based in United States, Canada and Switzerland. David R. Lowry's co-authors include Sidney O. Gottlieb, Thomas Guarnieri, Christopher M. O’Connor, Victor L. Serebruany, Alex I. Malinin, Jean-François Tanguay, Mark Midei, Charles H. Hennekens, David C. Sane and Steven R. Steinhubl and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

David R. Lowry

17 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Lowry United States 12 531 242 97 60 54 17 671
Carlo Giammarresi Italy 11 318 0.6× 298 1.2× 64 0.7× 83 1.4× 86 1.6× 26 661
Willy Weng Canada 8 354 0.7× 237 1.0× 109 1.1× 114 1.9× 55 1.0× 17 544
Simona Skerjanec United States 7 758 1.4× 495 2.0× 167 1.7× 31 0.5× 30 0.6× 8 929
Simon Kouz Canada 13 436 0.8× 254 1.0× 63 0.6× 28 0.5× 61 1.1× 34 710
Rosemary Ecob United Kingdom 7 523 1.0× 213 0.9× 199 2.1× 35 0.6× 37 0.7× 7 593
Ilaria Sestini Italy 10 413 0.8× 254 1.0× 62 0.6× 134 2.2× 126 2.3× 14 653
Rosa Coppolecchia United States 3 382 0.7× 183 0.8× 67 0.7× 121 2.0× 79 1.5× 5 525
H A Cameron United Kingdom 9 172 0.3× 119 0.5× 65 0.7× 42 0.7× 32 0.6× 14 420
Geneviève Le Calvez France 8 604 1.1× 271 1.1× 125 1.3× 155 2.6× 105 1.9× 14 905
Paul W.A. Janssen Netherlands 14 693 1.3× 354 1.5× 202 2.1× 61 1.0× 77 1.4× 30 792

Countries citing papers authored by David R. Lowry

Since Specialization
Citations

This map shows the geographic impact of David R. Lowry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Lowry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Lowry more than expected).

Fields of papers citing papers by David R. Lowry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Lowry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Lowry. The network helps show where David R. Lowry may publish in the future.

Co-authorship network of co-authors of David R. Lowry

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Lowry. A scholar is included among the top collaborators of David R. Lowry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Lowry. David R. Lowry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Midei, Mark, et al.. (2006). Rebound platelet activation after termination of prasugrel and aspirin therapy due to confirmed non-compliance in patient enrolled in the JUMBO Trial. International Journal of Clinical Practice. 60(7). 863–866. 25 indexed citations
3.
Serebruany, Victor L., Michael Miller, Alex Pokov, et al.. (2006). Effect of Statins on Platelet PAR-1 Thrombin Receptor in Patients With the Metabolic Syndrome (From the PAR-1 Inhibition by Statins [PARIS] Study). The American Journal of Cardiology. 97(9). 1332–1336. 58 indexed citations
4.
Serebruany, V. L., et al.. (2006). Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study. Postgraduate Medical Journal. 82(968). 404–410. 32 indexed citations
5.
Serebruany, Victor L., Mark Midei, Alex I. Malinin, et al.. (2004). Absence of Interaction Between Atorvastatin or Other Statins and Clopidogrel. Archives of Internal Medicine. 164(18). 2051–2051. 121 indexed citations
6.
Serebruany, Victor L., Alex I. Malinin, David R. Lowry, et al.. (2004). Effects of Valsartan and Valeryl 4-Hydroxy Valsartan on Human Platelets: A Possible Additional Mechanism for Clinical Benefits. Journal of Cardiovascular Pharmacology. 43(5). 677–684. 23 indexed citations
7.
8.
Nair, Girish V., Christopher J. Davis, Marcus E. McKenzie, David R. Lowry, & Victor L. Serebruany. (2001). Aspirin in Patients with Coronary Artery Disease: Is it Simply Irresistible?. Journal of Thrombosis and Thrombolysis. 11(2). 117–126. 4 indexed citations
9.
Serebruany, Victor L., et al.. (2000). Moderate Alcohol Consumption is Associated with Decreased Platelet Activity in Patients Presenting with Acute Myocardial Infarction. Journal of Thrombosis and Thrombolysis. 9(3). 229–234. 19 indexed citations
10.
Guarnieri, Thomas, et al.. (1999). Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial. Journal of the American College of Cardiology. 34(2). 343–347. 201 indexed citations
11.
Serebruany, Victor L., Selva R. Murugesan, Dan Atar, et al.. (1999). Increased Soluble Platelet / Endothelial Cellular Adhesion Molecule-1 and Osteonectin Levels in Patients with Severe Congestive Heart Failure. Independence of Disease Etiology, and Antecedent Aspirin Therapy. European Journal of Heart Failure. 1(3). 243–249. 41 indexed citations
12.
Gurbel, Paul A., Selva R. Murugesan, David R. Lowry, & Victor L. Serebruany. (1999). Plasma thromboxane and prostacyclin are linearly related and increased in patients presenting with acute myocardial infarction. Prostaglandins Leukotrienes and Essential Fatty Acids. 61(1). 7–11. 10 indexed citations
13.
Serebruany, Victor L., Paul A. Gurbel, Selva R. Murugesan, et al.. (1998). Depressed Plasma Platelet- Activating Factor Acetylhydrolasein Pat ients Presenting with Acute Myocardial Infarction. Cardiology. 90(2). 127–130. 20 indexed citations
14.
Serebruany, Victor L., Raymond D. Bahr, Christopher M. O’Connor, David R. Lowry, & Paul A. Gurbel. (1998). Antecedent Aspirin Therapy Inhibits Baseline Platelet Activity in Patients Presenting with Acute Myocardial Infarction. Cardiology. 90(1). 37–42. 9 indexed citations
15.
Bachorik, Paul S., et al.. (1991). Lipoprotein-Cholesterol Analysis during Screening: Accuracy and Reliability. Annals of Internal Medicine. 114(9). 741–747. 25 indexed citations
16.
Lowry, David R., et al.. (1987). [Effects of polymeric prostaglandin PGBx in cerebral ischemia].. PubMed. 38(3). 251–60. 2 indexed citations
17.
Lowry, David R., et al.. (1987). Anabolic steroid usage in weight-trained athletes. Health Education Research. 2(2). 157–160. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlo Giammarresi Breakdown of academic impact, for papers by Willy Weng Breakdown of academic impact, for papers by Simona Skerjanec Breakdown of academic impact, for papers by Simon Kouz Breakdown of academic impact, for papers by Rosemary Ecob Breakdown of academic impact, for papers by Ilaria Sestini Breakdown of academic impact, for papers by Rosa Coppolecchia Breakdown of academic impact, for papers by H A Cameron Breakdown of academic impact, for papers by Geneviève Le Calvez Breakdown of academic impact, for papers by Paul W.A. Janssen
Rankless by CCL
2026